Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1977
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA ; volume:38 ; number:2 ; day:17 ; month:2 ; year:2022 ; pages:103 ; date:2.2022
Drugs & therapy perspectives ; 38, Heft 2 (17.2.2022), 103, 2.2022
- Creator
-
Heo, Young-A
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40267-022-00901-1
- URN
-
urn:nbn:de:101:1-2022052720442605710256
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heo, Young-A
- SpringerLink (Online service)
Other Objects (12)
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials